The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis
NCT07513922 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2026-04-07
Summary
The Correlation between hs CRP TG triglycerides Glucose index in NAFLD and liver fibrosis
Conditions
- Liver Fibrosis
Interventions
- OTHER
-
• Fasting triglycerides (TG) • Fasting plasma glucose • High-sensitivity C-reactive protein (hs-CRP) • Liver enzymes (ALT, AST, GGT) • Platelet count • HbA1c • Lipid profile (total cholesterol, HDL-C,
Participants will be instructed to fast for 8-12 hours before blood sampling. Venous blood samples will be collected in the morning and analyzed in a certified laboratory for: * Fasting triglycerides (TG) * Fasting plasma glucose * High-sensitivity C-reactive protein (hs-CRP) * Liver enzymes (ALT, AST, GGT) * Platelet count * HbA1c * Lipid profile (total cholesterol, HDL-C, LDL-C)
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Essam Mohamed Abdelaziz ali, Professor
-
Ahmed Abdelfadeel Maghrraby hasdan, Lecturer
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-02
- Primary Completion
- 2027-10-02
- Completion
- 2027-12-02
Countries
- Egypt
Study Locations
More Related Trials
-
Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection
NCT05567614 ·Status: UNKNOWN
-
Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN
NCT06157125 ·Status: RECRUITING
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
NCT06739330 ·Status: RECRUITING
-
Effect of Thyroid Disorders in Liver Diseases
NCT06071923 ·Status: NOT_YET_RECRUITING
-
Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver
NCT06923215 ·Status: NOT_YET_RECRUITING
-
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
NCT06492369 ·Status: COMPLETED
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
NCT06097039 ·Status: COMPLETED
-
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
NCT04720560 ·Status: RECRUITING
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
NCT06119997 ·Status: RECRUITING
-
Relation Between NAFLD and BM DENSITY
NCT06038253 ·Status: NOT_YET_RECRUITING
-
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents
NCT03908294 ·Status: COMPLETED
-
Hepatic Fibrosis Non-invasive Methods Questionnaire
NCT02132351 ·Status: COMPLETED
-
Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV
NCT06589167 ·Status: NOT_YET_RECRUITING
-
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University Hospitals
NCT04482153 ·Status: UNKNOWN
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
NCT05790057 ·Status: UNKNOWN
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
NCT07175688 ·Status: COMPLETED
-
AI Models vs Non-Invasive Fibrosis Scores in MAFLD Diagnosis
NCT07305636 ·Status: COMPLETED
-
Omics-based Predictors of NAFLD/Potential NASH
NCT05301231 ·Status: UNKNOWN